Culture


Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10


The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.

How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9


The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.

How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8


The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7


The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."

Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6


The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.

Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5


The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.

We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4


The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.

How has Western influence changed the traditional use of iboga in Gabon? | Part 3


The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.

Taking Iboga with the People of Gabon | Part 2


The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.

Ibogaine presents unique challenges in how we approach harm reduction and treat addiction | Part 1


The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.

Applying to Law School on LSD


My decision to attend law school was unconventional, at best.

Johns Hopkins studying effects of psilocybin on brains of long-term meditators


Are these states really similar? Many meditators have answered quite clearly, yes.

Could Oregon be the First State to Legalize Psilocybin Therapy?


A group in Oregon is drafting a ballot initiative for 2020 that would allow individuals to take psilocybin in supervised settings.

Cocaine Tourism in Colombia


Medellín attracts the attention of tourists seeking a new kind of experience: doing cocaine in the city of Pablo Escobar.

The State: The Opioid Epidemic


For anyone who remembers the Reagan Administration's awesome response to the '80s crack epidemic, the Trump plan may prompt discouraging deja vu.

Maine Gov vetoes (admittedly flawed) legal cannabis bill, leaving future sales uncertain


On Friday, November 3, 2017, Maine Governor Paul LePage (R) vetoed legislation to regulate cannabis sales in the state.

Whitewashing Psychedelics: A Lack of Diverse Voices in the Psychedelic Movement


Nick Powers stands alone on stage as the only black speaker and the last voice to close out a conference on psychedelics.

Fear and Loathing on Flatbush Avenue


Fear and Loathing in Las Vegas can tell us a lot about the building of the system we are now finding ourselves stuck inside.

International Drug Policy Reform Conference Brings Harm Reduction into Spotlight


My destination was the International Drug Policy Reform Conference (Reform 2017). Judging by the throng of young college students crowding the lobby, I knew we were in the right place.

The State: Friday, Oct 27, 2017


To get a vision of the future of psychedelics from a legal and regulatory perspective, the most useful thing to do might be to see what's happening already in the realm of weed.

Culture


Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10


The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.

How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9


The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.

How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8


The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7


The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."

Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6


The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.

Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5


The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.

We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4


The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.

How has Western influence changed the traditional use of iboga in Gabon? | Part 3


The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.

Taking Iboga with the People of Gabon | Part 2


The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.

Ibogaine presents unique challenges in how we approach harm reduction and treat addiction | Part 1


The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.

Applying to Law School on LSD


My decision to attend law school was unconventional, at best.

Johns Hopkins studying effects of psilocybin on brains of long-term meditators


Are these states really similar? Many meditators have answered quite clearly, yes.

Could Oregon be the First State to Legalize Psilocybin Therapy?


A group in Oregon is drafting a ballot initiative for 2020 that would allow individuals to take psilocybin in supervised settings.

Cocaine Tourism in Colombia


Medellín attracts the attention of tourists seeking a new kind of experience: doing cocaine in the city of Pablo Escobar.

The State: The Opioid Epidemic


For anyone who remembers the Reagan Administration's awesome response to the '80s crack epidemic, the Trump plan may prompt discouraging deja vu.

Maine Gov vetoes (admittedly flawed) legal cannabis bill, leaving future sales uncertain


On Friday, November 3, 2017, Maine Governor Paul LePage (R) vetoed legislation to regulate cannabis sales in the state.

Whitewashing Psychedelics: A Lack of Diverse Voices in the Psychedelic Movement


Nick Powers stands alone on stage as the only black speaker and the last voice to close out a conference on psychedelics.

Fear and Loathing on Flatbush Avenue


Fear and Loathing in Las Vegas can tell us a lot about the building of the system we are now finding ourselves stuck inside.

International Drug Policy Reform Conference Brings Harm Reduction into Spotlight


My destination was the International Drug Policy Reform Conference (Reform 2017). Judging by the throng of young college students crowding the lobby, I knew we were in the right place.

The State: Friday, Oct 27, 2017


To get a vision of the future of psychedelics from a legal and regulatory perspective, the most useful thing to do might be to see what's happening already in the realm of weed.

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1